af (atrial fibrillation)

Rivaroxaban outperformed by VKAs for AF in rheumatic heart disease

Contrary to expectations, vitamin K antagonists (VKAs) reduced the risk of ischemic stroke and death compared with rivaroxaban, a factor Xa inhibitor (Xarelto, Janssen) in patients with rheumatic heart disease and atrial fibrillation, in the INVICTUS trial. Patients receiving a VKA, usually warfarin, had a 25% lower risk for the primary outcome – a composite …

Rivaroxaban outperformed by VKAs for AF in rheumatic heart disease Read More »

DANCAVAS suggests benefiting from a complete selection of CVs

Comprehensive imaging-based cardiovascular screening in men aged 65-74 did not significantly reduce all-cause mortality in a new Danish study, although there were strong suggestions of benefit for some cardiovascular parameters in the group as a whole and also for mortality in elderly people younger than 70. The DANCAVAS study was presented today at the European …

DANCAVAS suggests benefiting from a complete selection of CVs Read More »

DANCAVAS suggests benefiting from a complete selection of CVs

Comprehensive imaging-based cardiovascular screening in men aged 65-74 did not significantly reduce all-cause mortality in a new Danish study, although there were strong suggestions of benefit for some cardiovascular parameters in the group as a whole and also for mortality in elderly people younger than 70. The DANCAVAS study was presented today at the European …

DANCAVAS suggests benefiting from a complete selection of CVs Read More »